Sirtuins appear to have a complex but generally protective effect against obesity; increasing NAD+ levels or SIRT1 and SIRT6 activity may be a helpful therapeutic strategy for preventing and treating type 2 diabetes, MetS, and insulin resistance. This evidence concerns the gene SIRT1 and metabolic syndrome.